Concepedia

Kevin Coleman

KC

Statistics

Publications

31

Citations

6.5K

H-Index

24

Active since

1984

Affiliations

Arvinas (United States)(Current)

Pfizer (United States)

Yale University

University of California, San Francisco

Bristol-Myers Squibb (United States)

Kevin Coleman is an author at Arvinas (United States) specializing in medicine, cell biology, and tumor biology.

Top concepts

Publications per year

1984–2021

31

Publications

31

Hijacking the E3 Ubiquitin Ligase Cereblon to Efficiently Target BRD4

Jing Lü, Yimin Qian, Martha Altieri et al. · Chemistry & Biology · 2015 · 1.1K citations · Full text

, , +3

Expression of engrailed proteins in arthropods, annelids, and chordates

Nipam H. Patel, Enrique Martı́n-Blanco, Kevin Coleman et al. · Cell · 1989 · 1K citations

, , +5

Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Akt1 and Akt2

Xiao-ding Peng, Pei-Zhang Xu, Mei-Ling Chen et al. · Genes & Development · 2003 · 820 citations · Full text

PROTAC-induced BET protein degradation as a therapy for castration-resistant prostate cancer

Kanak Raina, Jing Lü, Yimin Qian et al. · Proceedings of the National Academy of Sciences · 2016 · 805 citations · Full text

Severe diabetes, age-dependent loss of adipose tissue, and mild growth deficiency in mice lacking Akt2/PKBβ

Robert S. Garofalo, Stephen Orena, Kristina Rafidi et al. · Journal of Clinical Investigation · 2003 · 711 citations · Full text

1–5 of 31